Birdwatch Archive

Birdwatch Note Rating

2024-04-01 11:47:04 UTC - HELPFUL

Rated by Participant: 85E9D1D5CBFCF2FC515C4D66958027F27B0C9A6D6E837598B280E5B4983D8BAE
Participant Details

Original Note:

Novo Nordisk spent over $2B in R&D over half a decade to make develop Ozempic. https://en.wikipedia.org/wiki/Semaglutide https://www.macrotrends.net/stocks/charts/NVO/novo-nordisk/research-development-expenses

All Note Details

Original Tweet

All Information

  • noteId - 1774520608384246241
  • participantId -
  • raterParticipantId - 85E9D1D5CBFCF2FC515C4D66958027F27B0C9A6D6E837598B280E5B4983D8BAE
  • createdAtMillis - 1711972024163
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 177452060838424624185E9D1D5CBFCF2FC515C4D66958027F27B0C9A6D6E837598B280E5B4983D8BAE